Search results for "gero"

showing 10 items of 2629 documents

Predictors of Participation and Autonomy in People With Multiple Sclerosis.

2019

Abstract Importance: Because multiple sclerosis (MS) affects many life areas, it is important to know how participation and autonomy are associated with the perceived impact of MS on everyday life. Objective: To investigate how perceived quality of life, disease impact, gender, and disease severity predict participation and autonomy in people with MS. Design: Cross-sectional study in which structural equation modeling was used to evaluate relationships between measured variables. Settings: Outpatient clinics in three areas and one inpatient rehabilitation center in Finland. Participants: Convenience sample of 194 people with MS. Outcomes and Measures: Participants completed the Impact on Pa…

Occupational therapyGerontology030506 rehabilitationmedicine.medical_specialtyExpanded Disability Status ScaleMultiple Sclerosismedia_common.quotation_subjectPsychological interventionStructural equation modeling03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Cross-Sectional StudiesOccupational TherapyScale (social sciences)medicineQuality of LifeOutpatient clinicHumans0305 other medical sciencePsychology030217 neurology & neurosurgeryAutonomyResearch Articlesmedia_commonThe American journal of occupational therapy : official publication of the American Occupational Therapy Association
researchProduct

Perceived barriers in the outdoor environment and development of walking difficulties in older people

2012

SIR—Older people with mobility limitations often report more barriers in their outdoor environment than people with intact mobility [1]. However, it is uncertain whether older people perceive their environment as problematic because of their mobility limitations or whether the environmental barriers precede incident mobility limitation, as most studies have been limited to cross-sectional analyses [2–5]. Only a few longitudinal studies have shown that barriers in the outdoor environment, such as poor street conditions, poor lighting and heavy traffic, increase the risk for overall functional loss [6, 7] and decrease physical activity participation [8]. More knowledge is needed about the cha…

Occupational therapyGerontologyMaleliikkumiskykyAgingmedicine.medical_specialtyympäristöPhysical activityWalkingHealth SciencesmedicineHumansProspective StudiesHeavy trafficMobility LimitationBaseline (configuration management)AgedRandomized Controlled Trials as TopicAged 80 and overbusiness.industryagingta3141General MedicineGerontology specializing in Medical and Health SciencesikääntyminenliikkuvuusMobility LimitationFemalePerceptionGeriatrics and GerontologyOlder peoplebusinessSocial psychologyFollow-Up Studies
researchProduct

L26 The Role Of Occupational Therapy In Huntington's Disease

2014

Background We discuss the role of the occupational therapist working with individuals and families affected by Huntington’s disease. Objectives A research by purposes was carried out through the design and implementation of an intervention program aimed at preventing and alleviating the deterioration caused by the disease through training in daily living activities and cognitive stimulation, and coaching the families through monthly monitoring and annual meetings. Method A literature review using structured databases was conducted to identify studies focusing on Occupational Therapy in Huntington’s disease. An intervention program based on the different types, symptoms and stages of the dis…

Occupational therapyGerontologyProgram evaluationmedicine.medical_specialtyActivities of daily livingbusiness.industryChoreaDiseasemedicine.diseaseCoachingPsychiatry and Mental healthHuntington's diseaseIntervention (counseling)MedicineSurgeryNeurology (clinical)medicine.symptombusinessPsychiatryJournal of Neurology, Neurosurgery & Psychiatry
researchProduct

Interventions aimed to increase independence and well-being in patients with Alzheimer’s disease: Review of some interventions in the Italian context

2018

Abstract Background Alzheimer's disease (AD) represents a huge social and economic burden for the society and caring for individuals with AD is a complex and challenging task that requires a multidisciplinary approach. Studies have shown that several interventions provide beneficial results, but some non-pharmacological interventions have not yet been studied in depth and clinical trials using them are still pending. This review provides a summary of interventions based on paradigms aimed to increase independence and well-being in people with AD, as well as those interventions that decrease caregiver burden in long-term facilties for AD patients in Italy. Methods Narrative review regarding …

Occupational therapyGerontologymedicine.medical_specialtybusiness.industryGeneral NeurosciencePsychological interventionContext (language use)Caregiver burdenmedicine.diseaseClinical trial03 medical and health sciencesPsychiatry and Mental health0302 clinical medicineQuality of life (healthcare)Multidisciplinary approachmedicineDementia030212 general & internal medicineNeurology (clinical)business030217 neurology & neurosurgeryNeurology, Psychiatry and Brain Research
researchProduct

Life-Space Mobility in Parkinson's Disease: Associations with Motor and Non-Motor Symptoms.

2019

Background To describe life-space mobility and explore associations of motor and non-motor symptoms with life-space mobility in people with Parkinson’s disease (PD). Methods About 164 community-dwelling persons with PD (mean age 71.6 years, 64.6% men) received a postal survey and a subsequent home visit. Motor assessments included perceived walking difficulties (Walk-12G), mobility (Timed Up and Go test), motor symptoms (UPDRS-III), and freezing of gait (item 3, FOG-Qsa). Non-motor symptoms included depressive symptoms (GDS-15), pain, fatigue (NHP-EN), and global cognition (MoCA). Life-space mobility was assessed with the life-space assessment (LSA). Calculations included composite score (r…

Occupational therapyMaleAgingmedicine.medical_specialtyNeurologyParkinson's diseaseParkinsonin tautiDiseaseTimed Up and Go testelämänlaatuMotor Activity03 medical and health sciences0302 clinical medicineliikuntakykyparticipationMedicineassistive devicesHumans030212 general & internal medicineLongitudinal StudiesMobility LimitationFatigueosallistuminenAgedAged 80 and overbusiness.industryConfoundingCognitionParkinson Diseaseta3142apuvälineetMiddle Agedmedicine.diseaseGaitmobilityliikkuvuusPhysical therapyLinear ModelsFemaleIndependent LivingGeriatrics and Gerontologybusinesshuman activities030217 neurology & neurosurgerywalking difficultiesThe journals of gerontology. Series A, Biological sciences and medical sciences
researchProduct

Attributes and definitions of locomotor capacity in older people: a World Health Organisation (WHO) locomotor capacity working group meeting report

2022

not available

Older PeopleLocomotor capacity · Older people · Attributes · Conceptual definitionAgingConceptual definitionLocomotor capacityAttributesGeriatrics and GerontologyAging Clinical and Experimental Research
researchProduct

Erratum to: Development and validation of the FRAGIRE tool for assessment an older person’s risk for frailty

2016

Background Frailty is highly prevalent in elderly people. While significant progress has been made to understand its pathogenesis process, few validated questionnaire exist to assess the multidimensional concept of frailty and to detect people frail or at risk to become frail. The objectives of this study were to construct and validate a new frailty-screening instrument named Frailty Groupe Iso-Ressource Evaluation (FRAGIRE) that accurately predicts the risk for frailty in older adults. Methods A prospective multicenter recruitment of the elderly patients was undertaken in France. The subjects were classified into financially-helped group (FH, with financial assistance) and non-financially …

Older personGerontologyRehabilitationFrailtybusiness.industryGeriatrics gerontologymedicine.medical_treatmentPublished ErratumMEDLINEEvaluation toolLoss of autonomy03 medical and health sciencesElderly0302 clinical medicinemedicine030212 general & internal medicineGeriatrics and Gerontologybusiness030217 neurology & neurosurgeryResearch ArticleBMC Geriatrics
researchProduct

Age differences in olfactory affective responses: evidence for a positivity effect and an emotional dedifferentiation

2021

International audience; Studies on aging and hedonic judgment of odors have never been addressed within the empirical frameworks of age-related changes in emotion which state that advancing age is associated with a reduced negativity bias and a less pronounced differentiation between hedonic valence and emotional intensity judgments. Our aim was to examine and extend these age-related effects into the field of odors. Thirty-eight younger adults and 40 older adults were asked to evaluate the hedonic valence, emotional intensity, and familiarity of 50 odors controlled for their pleasantness. Compared to younger adults, older adults rated unpleasant odorants as less unpleasant and showed an in…

Olfactory perceptionAdultMalePleasureAgingEmotionsExperimental and Cognitive PsychologyEmotional intensity050105 experimental psychologyDevelopmental psychology03 medical and health sciencesYoung Adult0302 clinical medicineemotional dedifferentiationolfactory perceptionemotional intensityHumans0501 psychology and cognitive sciencesPositivity effectAgedreduced negativity biasAge differences[SDV.NEU.PC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Psychology and behavior05 social sciencesAge FactorsRecognition PsychologyMiddle AgedPsychiatry and Mental healthNeuropsychology and Physiological Psychologyhedonic valenceFemalesense organsGeriatrics and GerontologyPsychology030217 neurology & neurosurgerypsychological phenomena and processes
researchProduct

Moderate hypofractionated helical tomotherapy for prostate cancer in a cohort of older patients: a mono-institutional report of toxicity and clinical…

2019

Purpose or objective: To evaluate toxicity and outcomes of moderately hypofractionated helical tomotherapy for the curative treatment of a cohort of patients aged ≥ 75 years with localized prostate cancer (PC). Materials and methods: From January 2013 to February 2017, 95 patients with median age 77 years (range 75–88) were treated for PC. 39% were low risk, 33% intermediate risk (IR), 28% high risk (HR). Median iPSA was 9.42 ng/ml (1.6–107). Androgen deprivation was prescribed according to NCCN recommendations. All patients received 70 Gy in 28 fractions to the prostate; 61.6 Gy were delivered to the seminal vesicles for IR; whole pelvis irradiation with a total dose of 50.4 Gy was added i…

OncologyMaleAgingmedicine.medical_specialtymedicine.medical_treatmentTomotherapyCohort Studies03 medical and health sciencesProstate cancer0302 clinical medicineQuality of lifeStatistical significanceInternal medicinemedicineHumans030212 general & internal medicineAgedAged 80 and overbusiness.industryProstatic NeoplasmsAndrogen AntagonistsMiddle Agedprostate cancermedicine.diseaseRadiation therapyTreatment OutcomeToxicityCohortQuality of LifeRadiotherapy Intensity-ModulatedGeriatrics and Gerontologybusiness030217 neurology & neurosurgeryCohort studyAging clinical and experimental research
researchProduct

The prevalent KRAS exon 2 c.35 G > A mutation in metastatic colorectal cancer patients: a biomarker of worse prognosis and potential benefit of bevac…

2015

Bevacizumab-containing chemotherapy differently predict increased efficacy in KRAS exon 2 mutant and wild-type metastatic colorectal cancer (MCRC) patients. Mutant compared to wild-type status did not significantly affect progression-free survival (PFS) and overall survival (OS) in patients fit for first line bevacizumab-containing FIr-B/FOx regimen, and after progression. In patients unfit for intensive regimens, mutant status significantly affected PFS, while not OS. Codon 12 KRAS mutations differentially affect GTPase function, and confer worse clinical behaviour. Prognostic relevance of the prevalent c.35 G. >. A KRAS mutation was retrospectively evaluated. Fit c.35 G. >. A mutant patie…

OncologyVascular Endothelial Growth Factor APathologyKRAS c.35 G>A mutationColorectal cancermedicine.medical_treatmentMutantIntensive regimenColorectal Neoplasmmedicine.disease_causeExonMutation RateAntineoplastic Combined Chemotherapy ProtocolsNeoplasm MetastasisProto-Oncogene ProteinMetastatic colorectal cancerHematologyExonsPrognosisNeoplasm MetastasiBevacizumabTreatment OutcomeOncologyDisease ProgressionBiomarker (medicine)KRASColorectal NeoplasmsHumanmedicine.drugmedicine.medical_specialtyBevacizumabGenotypePrognosiExonAntibodies Monoclonal HumanizedProto-Oncogene Proteins p21(ras)Internal medicineProto-Oncogene ProteinsmedicineHumansChemotherapyAntineoplastic Combined Chemotherapy Protocolbusiness.industryBiomarkerras Proteinmedicine.diseaseRegimenMutationras ProteinsBevacizumab; Biomarker; Intensive regimens; KRAS c.35 G>A mutation; Metastatic colorectal cancer; Antibodies Monoclonal Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers; Colorectal Neoplasms; Disease Progression; Genotype; Humans; Mutation Rate; Neoplasm Metastasis; Prognosis; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Treatment Outcome; Vascular Endothelial Growth Factor A; ras Proteins; Exons; Mutation; Hematology; Oncology; Geriatrics and GerontologyGeriatrics and GerontologybusinessBiomarkers
researchProduct